MedTrace Logo

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)

NCT06290427 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-01-03

No results posted yet for this study

Summary

The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms:

* DaVinci®;
* Hugo®.

The questions it aims to answer are:

Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable?

Participants will be invited to join one of these two experimental group:

1. surgery with the DaVinci platform;
2. surgery with the Hugo platform.

Conditions

  • Renal Carcinoma

Interventions

DEVICE

DaVinci RAPN

Robot-assisted Partial Nephrectomy with DaVinci® Surgical System

DEVICE

Hugo RAS RAPN

Robot-assisted Partial Nephrectomy with Hugo™ RAS System

Sponsors & Collaborators

  • Azienda Ospedaliera Universitaria Integrata Verona

    lead OTHER

Principal Investigators

  • Alessandro AA Antonelli, MD · Azienda Ospedaliera Universitaria Integrata Verona

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2024-12-12
Completion
2025-06-30
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06290427 on ClinicalTrials.gov